InvestorsHub Logo
Post# of 252252
Next 10
Followers 13
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

Re: ThomasS post# 44008

Friday, 03/30/2007 11:04:47 AM

Friday, March 30, 2007 11:04:47 AM

Post# of 252252
"Advisory Committee voted 13-4 to recommend DNDN's Provenge immunotherapy for prostate cancer with very limited data (only 82 treated patients with just 21% increase in survival)."

This is good.
The last weekend I attended a casino and played a roulette. At one moment "RED" numbers came 11 times out of 12 spins. This did and could happened only because the sampling was very small. However, my experience does not in any way invalidate laws of mathematics.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.